Versigent (NYSE:VGNT – Get Free Report) was upgraded by investment analysts at Argus to a “strong-buy” rating in a research report issued on Tuesday,Zacks.com reports.
A number of other analysts also recently issued reports on the stock. Royal Bank Of Canada raised their price target on shares of Versigent from $34.00 to $41.00 and gave the company a “sector perform” rating in a report on Monday, July 13th. The Goldman Sachs Group initiated coverage on shares of Versigent in a report on Monday. They set a “buy” rating and a $48.00 price objective for the company. Oppenheimer set a $50.00 price objective on shares of Versigent in a research report on Tuesday. Zacks Research raised shares of Versigent from a “hold” rating to a “strong-buy” rating in a research report on Thursday, July 2nd. Finally, Evercore reiterated an “outperform” rating and set a $60.00 target price on shares of Versigent in a research note on Monday, May 18th. Four investment analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $49.67.
Check Out Our Latest Report on VGNT
Versigent Stock Up 2.8%
Recommended Stories
- Five stocks we like better than Versigent
- Confidence Is Back, But Earnings Show the Consumer Is Being Picky
- AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off
- 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative?
- 3 Photonics Companies Making Quantum Tech Possible
Receive News & Ratings for Versigent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Versigent and related companies with MarketBeat.com's FREE daily email newsletter.
